Are you Dr. Weinstein?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 13 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1656 N California Blvd
Suite 200
Walnut Creek, CA 94596Phone+1 925-952-2888Fax+1 925-952-2845
Summary
- Dr. Richard Weinstein, MD is an endocrinologist in Walnut Creek, California. He is currently licensed to practice medicine in California.
Education & Training
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1964 - 1966- Mount Sinai Medical Center of ClevelandInternship, Transitional Year, 1963 - 1964
University of Virginia School of MedicineClass of 1963
Certifications & Licensure
CA State Medical License 1971 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- The Effect of Betahistine on Body Weight in Obese Subjects Start of enrollment: 2007 Jan 01
- Study of DA-9801 to Treat Diabetic Neuropathy Start of enrollment: 2013 Nov 01
- A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 175 citationsContinuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.Philip Raskin, Bruce W. Bode, Jennifer B. Marks, Irl B. Hirsch, Richard L. Weinstein
Diabetes Care. 2003-09-01 - 98 citationsComparison of Insulin Aspart With Buffered Regular Insulin and Insulin Lispro in Continuous Subcutaneous Insulin Infusion: A randomized study in type 1 diabetesBruce W. Bode, Richard L. Weinstein, Derek Bell, Janet B. McGill, Daniel Allen Nadeau
Diabetes Care. 2002-03-01 - 21 citationsImpact of Mifepristone, a Glucocorticoid/Progesterone Antagonist, on HDL Cholesterol, HDL Particle Concentration, and HDL FunctionStephanie T. Page, Ronald M. Krauss, Coleman Gross, Brian Y. Ishida, Jay W. Heinecke
The Journal of Clinical Endocrinology and Metabolism. 2012-03-07
